This Study in Healthy Men and Women Tests How the Body Takes up BI 409306
NCT03505151 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2024-08-20
Summary
The primary objective of this trial is to investigate the absolute bioavailability of BI 409306. The secondary objective is the evaluation and comparison of several pharmacokinetic parameters for the different treatments.
Conditions
- Healthy
Interventions
- DRUG
-
BI 409306 (C-13/N-15)
i.v solution
- DRUG
-
BI 409306
Film-coated tablet
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-27
- Primary Completion
- 2018-05-19
- Completion
- 2018-05-19
Countries
- Germany
Study Locations
More Related Trials
-
Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers
NCT02173652 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body
NCT06572111 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood
NCT04426851 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers
NCT01841112 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183298 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
NCT05707403 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects
NCT03100903 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers
NCT02215759 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated
NCT03315936 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers
NCT02183610 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers
NCT03151499 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
NCT03971695 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
NCT06957756 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469
NCT01971502 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers
NCT02223507 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667
NCT02133482 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects
NCT02183493 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food
NCT04789291 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy Volunteers
NCT02222168 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Single Rising Doses and Relative Bioavailability of BI 691751
NCT01843972 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food
NCT05337592 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers
NCT02215772 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated
NCT05985200 ·Status: COMPLETED ·Phase: PHASE1